Sign in
Active, not recruitingPhase 2

Nightmare Deconstruction and Reprocessing vs. NightWare Wristband

Key facts

Who runs it
Uniformed Services University of the Health Sciences
Where
Bethesda, United StatesSee the site
Trial code
Status
Active, not recruiting
Phase
Phase 2
People taking part
30 people, planned
Started
11 Jun 2024
Expected to end
Dec 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Nightmare Deconstruction and Reprocessing
  • NightWare
Record updated
1 October 2026

Who can take part

Age
22 years to 64 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Active duty service members and veterans
  • Minimum symptom severity:
  • Has had at least 1 nightmare per week for the past month
  • Has a minimum ISI score of 8
  • If taking medications for PTSD, depression, anxiety, or insomnia, must be on stable dose for 8 weeks

Who cannot take part

  • Psychosis, bipolar disorder, or alcohol or substance use disorder
  • REM sleep behavior disorder or narcolepsy as determined by investigator
  • Serious risk of suicide
  • Untreated moderate to severe sleep apnea
  • Use of synthetic glucocorticoid beta blockers, prazosin, or varenicline
  • Current evidence-based or experimental psychotherapy directly targeting nightmares, insomnia, or PTSD
  • Inability to recall nightmare content
  • Inability to wear wristband or sync wristband data
  • Inability to comply with blood draws
  • Refusal to consent to DNA analysis of blood samples
  • Refusal to consent to audio recording of study visits

Where in United States

  • Uniformed Services University of the Health SciencesBethesda, United States

About the trial

What the trial wants to find out

The overall goal of this Phase IIa randomized controlled pilot trial is to assess the potential efficacy of two emerging treatments for post-trauma nightmares and to test the feasibility of study design and methods. Symptom change will be assessed in two treatment arms: (1) Nightmare Deconstruction and Reprocessing (NDR), an exposure-based psychotherapy; and (2) NightWare (NW), a non-exposure approach using a wristband device. The investigators will also assess the feasibility of circadian-dependent blood sampling and use of another wristband to collect physiologic data. Specific aims are: (1) Compare evidence of how well participants tolerate and comply with the two treatments and test feasibility of methods and procedures; (2) Collect additional evidence of the potential efficacy of two contrasting non-pharmacologic approaches to treating posttraumatic nightmares; (3) Explore the operational stress index (OSI) as a reliable, objective measure of sleep disturbance and nightmare events.

The 2 groups in the trial

  • Nightmare Deconstruction and ReprocessingTreatment being tested

    Psychotherapy that uses exposure to nightmare images for trauma activation with the goal of memory reconsolidation.

  • NightWareTreatment being tested

    Wristband device that detects physiologic signals during sleep that indicate a possible nightmare and gently vibrates to rouse the sleeper without fully waking them.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pilot Trial Comparing Exposure and Nonexposure Treatments for Posttrauma Nightmares and Insomnia: Nightmare Deconstruction and Reprocessing vs. NightWare Wristband
Record updated
1 October 2026